The Clinical Trial Is Open. The Elderly Need Not Apply
The New York Times (13 April 2018):
Geriatricians have complained for years that figuring out treatments for their patients becomes dramatically more difficult when older people are excluded from clinical trials and other research.
For an 83-year-old, what are the risks and benefits of a surgical procedure, drug or medical device tested primarily on those in their 50s? When a drug trial excludes those who have several diseases and take other drugs, how do the results pertain to older adults — most of whom have several diseases and take other drugs?
Too often, doctors resort to extrapolation — or, to put it less politely, guessing.